Grandfield & Dodd LLC Purchases 76,035 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Grandfield & Dodd LLC raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 34.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 298,885 shares of the company's stock after buying an additional 76,035 shares during the quarter. GE HealthCare Technologies makes up approximately 1.6% of Grandfield & Dodd LLC's holdings, making the stock its 24th largest holding. Grandfield & Dodd LLC owned 0.07% of GE HealthCare Technologies worth $23,110,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in GEHC. Barclays PLC acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at about $92,462,000. Thrivent Financial for Lutherans acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at about $1,590,000. MML Investors Services LLC acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at about $929,000. Schonfeld Strategic Advisors LLC acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at about $3,474,000. Finally, Tower Research Capital LLC TRC acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at about $1,150,000. Hedge funds and other institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Stock Down 0.6 %

Shares of GEHC traded down $0.48 during trading on Friday, reaching $84.49. The company's stock had a trading volume of 2,022,710 shares, compared to its average volume of 2,568,032. The company has a fifty day moving average of $88.74 and a two-hundred day moving average of $77.89. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.50. The company has a market cap of $38.56 billion, a price-to-earnings ratio of 27.98, a P/E/G ratio of 2.96 and a beta of 0.94. The company has a quick ratio of 0.83, a current ratio of 1.05 and a debt-to-equity ratio of 1.18.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The company had revenue of $5.20 billion for the quarter, compared to analyst estimates of $5.09 billion. During the same period in the prior year, the company posted $1.31 EPS. GE HealthCare Technologies's quarterly revenue was up 5.3% on a year-over-year basis. On average, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be issued a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.97%.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on GEHC. HSBC began coverage on GE HealthCare Technologies in a research note on Thursday, February 15th. They issued a "buy" rating and a $100.00 price objective on the stock. Evercore ISI boosted their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an "outperform" rating in a research report on Thursday, April 4th. UBS Group raised GE HealthCare Technologies from a "sell" rating to a "neutral" rating and boosted their price target for the stock from $66.00 to $88.00 in a research report on Monday, February 12th. Argus boosted their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a "buy" rating in a research report on Monday, April 1st. Finally, Morgan Stanley boosted their price target on GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an "equal weight" rating in a research report on Monday, February 12th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $95.09.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.